Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial.

Wong, Chee Wai; Wong, Edmund; Metselaar, Josbert M; Storm, Gert; Wong, Tina T

Wong, Chee Wai; Wong, Edmund; Metselaar, Josbert M; Storm, Gert; Wong, Tina T.

Afiliación

Wong CW; Singapore National Eye Centre (SNEC), 11 Third Hospital Avenue, Singapore City, 168751, Singapore.
Wong E; Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore City, 168751, Singapore.
Metselaar JM; Duke-National University of Singapore Medical School, 8 College Rd, Singapore City, 169857, Singapore.
Storm G; Singapore National Eye Centre (SNEC), 11 Third Hospital Avenue, Singapore City, 168751, Singapore.
Wong TT; Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore City, 168751, Singapore.

Drug Deliv Transl Res ; 12(1): 7-14, 2022 01.

Article en En | MEDLINE | ID: mdl-33569720

Asunto(s)

Catarata; Anciano; Antiinflamatorios/uso terapéutico; Catarata/inducido químicamente; Sistemas de Liberación de Medicamentos; Femenino; Humanos; Liposomas; Masculino; Persona de Mediana Edad

Palabras clave

Cataract surgery; Drug delivery; Inflammation; Liposomal; Prednisolone phosphate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catarata Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Drug Deliv Transl Res Año: 2022 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google